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Helicobacter pylori is the principal species of the genus Helicobacter 
that inhabits the gastric mucosa of the human stomach. It chronically 
infects billions of people worldwide,1-3 and is responsible for one of 
the most frequent chronic bacterial infections involving more than 
50% of the world’s population.4 H. pylori is one of the most genetically 
diverse of bacterial species, and is a major cause of at least 90% 
of duodenal ulcers (DUs), 70% of  gastric ulcers (GUs), non-ulcer 
dyspepsia (NUD) and gastro-oesophageal reflux disease (GORD).5,6 
It plays a role in adenocarcinoma of the distal stomach, mucosa-
associated lymphoid tissue lymphoma (MALT) and primary gastric 
non-Hodgkin’s lymphoma, in many societies.3,7 H. pylori’s ability to 
adhere, invade and evade host defences and cause tissue damage is 
largely due to its production of colonisation and virulence factors.8
The prevalence of H. pylori infection increases with advancing age 
and is higher in developing countries and among low socio-economic 
populations, probably owing to conditions that favour the infection, 
such as poor hygiene, crowded living conditions, and inadequate or 
no sanitation.1,9-11
Although the geographical and socio-demographic prevalence of 
human infection by H. pylori varies,1,11 prevalence does not parallel 
the incidence of morbidity caused by the infection. In Africa, 
for example, H. pylori infection is common1,2,10,11 and is the main 
cause of at least 90% of duodenal ulcers and 70% of gastric ulcers 
on the continent.2,10 Involvement of H. pylori in gastric patients 
in Cameroon2 revealed a similar pattern to that recorded among 
Ghanian patients12 with dyspeptic symptoms and in South African 
patients with NUD.13
The prevalence of H. pylori infection differs in relation to ethnic 
groups, races and economic conditions.14 H. pylori infection seems 
to be common in South Africa, as might be expected in developing 
countries.15,16 Although studies have reported the prevalence of the 
organism in the country, most adopted a sero-prevalence approach, 
which does not provide more information other than the presence 
of antibodies, which are poor markers of active infection. In Cape 
Town, a prevalence of 63% of the pathogen in NUD patients based 
on histology reports was documented,13 and a prevalence of 81% in 
NUD patients based on serology testing.17
Published data on the prevalence of the organism in dyspeptic 
patients in the Eastern Cape province, which is predominantly 
rural with poor sanitation and household hygiene (factors that 
favour the spread of H. pylori), are lacking. Therefore, investigating 
its prevalence in the province based on race and disease profile is 
important in forming the basis of future clinical and epidemiological 
studies.
Methods
Subjects
We evaluated 254 consecutive patients referred for endoscopy at 
Livingstone Hospital, Port Elizabeth, between May and December 
2008. The nature and purpose of the study was explained to the 
patients until they fully understood. We enrolled only patients who 
gave informed consent; who had not received treatment with broad-
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Objectives. We examined Helicobacter pylori infection in patients 
with gastric-related morbidities at Livingstone Hospital, Port 
Elizabeth, to determine the prevalence and risk factors for infection 
according to race, endoscopic diagnosis, age and sex.
Methods. Gastric biopsies were collected from 254 consecutive 
patients and H. pylori was isolated on Columbia agar base 
supplemented with 7% sheep’s blood and Skirrow’s supplement 
containing trimethoprim (2.5 mg), vancomycin (5 mg) and 
cefsulodin (2.5 mg). Amphotericin (2.5 mg) was added to the 
medium. Recovered isolates were identified following standard 
microbiology and biochemical techniques. Presumptive isolates 
were further confirmed by polymerase chain reaction (PCR) 
targeting the glmM gene. Fisher’s exact test was used to assess 
the univariate association between H. pylori infection and the 
possible risk factors. Odds ratios (ORs) and corresponding 95% 
confidence intervals (CIs) were calculated to measure the strength 
of association, using EPI INFO 3.41 software. p-values <0.05 were 
required for significance.
Results. The overall prevalence of H. pylori was 66.1% (168/254). 
Of the 168 positive subjects, H. pylori prevalence was highest in 
patients with non-ulcer dyspepsia (NUD) (32.7%; 55/168), and 
lowest (0%; 0/168) in those with atypical oesophageal reflux disease 
and gastroduodenitis, respectively. The prevalence of infection was 
highest among coloureds (68.4%; 89/130) and lowest in whites 
(59.5%; 25/42). Prevalence increased with age.
Conclusion. The prevalence of H. pylori is high in dyspeptic 
patients in Eastern Cape province. Gender, antibiotic treatment 
and alcohol consumption may be risk factors for infection. These 
findings are of clinical and epidemiological significance.
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spectrum antibiotics, non-steroidal anti-inflammatory drugs or 
proton pump inhibitors in the previous 3 months; and who did not 
have a history of dysphagia, gastric surgery or upper gastro-intestinal 
bleeding. The study was approved by the institutional review board 
of the University of Fort Hare and the Eastern Cape Department of 
Health (Protocol number EcDoH-Res 0002).
Endoscopy, questionnaire and culture for H. 
pylori
All patients underwent a complete physical examination and history 
was taken by a resident gastro-enterologist. Endoscopic diagnoses 
were made by a single experienced endoscopist to rule out observer 
bias. The diagnoses were made on the macroscopic appearance of 
obviously inflamed mucosa at endoscopy, i.e. hyperaemic oedematous 
mucosa sometimes with contact bleeding to delineate the different 
clinical conditions associated with infection. Race, smoking, alcohol 
intake and demographic data were recorded. Some patients had 
previously undergone H. pylori eradication therapy.
Two antral and corpus biopsy specimens each were obtained at 
endoscopy for a total of 1 016 specimens, which were immediately 
placed in sterile bijou bottles containing 0.2 g/l of cysteine and 
20% glycerol in brain-heart infusion (BHI) broth and transported 
in ice to the laboratory within 2 hours of collection for culture and 
characterisation as previously reported.2 Presumptive isolates were 
confirmed by polymerase chain reaction (PCR) targeting the glmM 
gene as previously reported.18 A reference strain of H. pylori (NCTC 
11638) was included as a positive control. Confirmed isolates were 
suspended in 20% glycerol and stored at -80ºC in a freezer (Sanyo, 
Japan) for future experiments.
Statistical analysis
An SPSS program was used to determine Pearson’s chi-square test and 
Fisher’s exact test. Fisher’s exact test was used to assess the univariate 
association between H. pylori infection and the possible risk factors. 
Odds ratio (OR) and the corresponding 95% confidence interval 
(CI) were calculated to measure the strength of association using EPI 
INFO 3.41 package (Centers for Disease Control and Prevention, 
Atlanta, GA, USA). p-values <0.05 were required for significance.
Results
A total of 254 patients were enrolled. Their mean age was 44.5±15.7 
years (range 5 - 93 years), and 83.1% (211/254) were older than 
35 years. There were 90 males and 164 females (male/female ratio 
1:1.8).
Endoscopy was performed on all 254 enrolled patients. Of the 
abnormal findings, NUD was the most common (33.8%; 86/254), 
followed by GORD (17.7%; 45/254), DU (15.7%; 40/254), and GU 
(9.4%; 24/254) (Table I).
Of the 254 subjects, 168 had H. pylori-positive culture, giving an 
overall prevalence of 66.1%. A total of 592 H. pylori strains were 
obtained from the 1 016 biopsy specimens (508 antral and 508 
corpus). This was confirmed by PCR as we obtained the expected 1.1 
kilobase for the organism. The mean incubation time was 4 days. The 
percentage positivity for antrum was 61.0% (310/508), and for corpus 
55.5% (282/508).
Of our 168 positive subjects, H. pylori prevalence was highest 
in patients with NUD (32.7%; 55/168) and lowest (0%; 0/168) in 
those with atypical oesophageal reflux disease and gastroduodenitis 
respectively (Table I). Also, of the 254 enrolled subjects, the prevalence 
of H. pylori in relation to endoscopic findings was highest (100%) in 
patients with duodenitis (1/1), gastric cancer (GC) (4/4) and gastric 
erosion (5/5), as they were all positive for the organism. However, 
patients with gastritis (6/8; 75%), GU (17/24; 70.8%), DU (26/40; 
65%), NUD (55/85; 64.7%), and GORD (29/45; 64.4%) also had high 
prevalence rates for the organism (Table I).
Of the 254 enrolled patients, 82 (32.2%) were black, 130 (51.1%) 
were coloured and 42 (16.5%) were white. H. pylori prevalence 
was highest among the coloureds (68.4%; 89/130), followed by 
blacks (65.8%; 54/82) and whites (59.5%; 25/42). The prevalence 
of the organism by gender in these three racial groups was highest 
among black females (71.6%; 38/53), followed by whites (68.1%; 
15/22) and coloureds (67.7%; 61/90). In males, the prevalence was 
highest among the coloured group (70%; 28/40), followed by the 
black (55.1%; 16/29) and white (50%; 10/20) groups. Differences 
between the racial groups, sex and age were, however, not statistically 
significant (p>0.05).
The prevalence of H. pylori infection increased with age (Table II). 
Regarding sex, 114 (69.5%) of the 164 enrolled females were positive, 
while 54 (60%) of the 90 males were positive.
The prevalence of H. pylori related to alcohol consumption and 
smoking, respectively, was also investigated. Of the 168 subjects 
positive for H. pylori, 71 (42.3%) were smokers and 46/86 (53.5%) 
non-smokers; and 60/168 (35.7%) positive subjects drank alcohol, 
while 28/86 (32.6%) did not (Table II).
Discussion
The high prevalence in Africa of human infection by H. pylori indicates 
that effective public health interventions should be developed. 
The variations in its prevalence between and among populations 
could indicate that factors including age, cultural background, 
genetic predisposition, socio-economic status and environmental 
conditions all play a role in the acquisition and transmission of the 
organism.11,12 Within countries, the prevalence among more affluent 
urban populations and poor rural populations can vary widely.11,12
All the dyspeptic patients investigated in this study presented 
with signs of gastric-related morbidities at the endoscopic unit of 
Livingstone Hospital in Port Elizabeth. We used cultures (confirmed 
by molecular techniques) to investigate the prevalence of H. pylori 
infection among dyspeptic patients and also to delineate  the risk 
factors for infection among ethnic groups and races related to 
other demographic characteristics. Although some authors have 
dismissed culture as the gold standard for H. pylori diagnosis, others 
have proved it useful in large-scale epidemiological studies and 
in laboratories with limited resources in the developing world.2,19 
Culture also enabled us to determine the susceptibility patterns of our 
isolates to guide empiric treatment.20
Our overall prevalence finding of 66.1% (168/254) is similar 
to studies in Cameroon, Cote d’Ivoire, Egypt, Ghana, Kenya, 
Korea, Malawi, Nigeria, South Africa, Zaire and Zimbabwe (60 - 
94%).2,9,12,21 Kidd et al.22 also reported that endoscopic studies in 
dyspeptic individuals in Africa revealed the presence of the organism 
in most subjects.  Previous South African studies10,13,17 had equally 
incriminated this organism in cases of duodenal and gastric ulcers.
By endoscopic diagnosis, H. pylori prevalence was highest (100%) 
among patients with duodenitis (1/1), GC (4/4) and gastric erosion 
(5/5). Our reported prevalence of 100% (4/4) in patients with GC by 
endoscopic diagnosis and H. pylori prevalence is very high compared 
with other studies in Africa, and differs from the findings of Uemura 
et al.23 (considering only those with GC) who reported GC in 2.9% 
of H. pylori-infected and none of their uninfected patients. However, 
the possible reason for our unusually high prevalence could be linked 
to the different sample sizes used in these studies. Only 4 of our 
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254 patients had GC, giving an overall prevalence of 2.38% which, 
considering the overall study subjects, is in line with the findings of 
Uemura et al.23
Another consideration is that South Africa has a heterogeneous 
population including whites whose ancestral background is in the 
Western world where GC is high;23 our 4 patients with GC were 
white. GC is a terminal condition for H. pylori-positive patients; 
hence, a patient once identified as having GC will invariably have 
the infection. Also, GC develops in persons with H. pylori but not in 
uninfected persons.23
Patients with gastritis (75%; 6/8), GU (70.8%; 17/24), DU (65%; 
26/40), NUD (64.7%; 55/85), and GORD (64%; 29/45) also had high 
prevalence rates of the organism, which corroborates the findings 
of others7,21 who reported either one or two of the above clinical 
conditions as the most common endoscopic findings in H. pylori 
infection. It has been suggested that up to 95% of DUs and 70% of 
GUs are attributable to infection by this pathogen, and most cases 
occur in middle-aged subjects.2,10
Significantly, our results are consistent with previous studies in 
South Africa.13,17 Louw et al.13 documented an overall incidence of H. 
pylori infection in 80% of GU and 95% of DU patients, and O’Keefe 
et al.17 reported overall H. pylori prevalence of 80%, with prevalence 
rates of 78%, 81%, and 81% in patients with GC, peptic ulcer (PU) 
and NUD, respectively.
The prevalence of H. pylori infection was highest among the 
coloured (68.4% – 87/130) and black subjects (65.8% – 54/ 82) and 
lowest in whites (59.5% – 25/42). There was no statistically significant 
difference between the races, in contrast with the findings of Louw 
et al.10 in the Western Cape province, where they demonstrated 
a significant difference: a prevalence of 40% in white and 71% in 
Table I. Gastro-duodenal pathologies and prevalence of H. pylori infection in 254 patients referred for endoscopy
                        H. pylori positive (%)
Endoscopic categories                No. of cases (%)       Endoscopic diagnosis             Study subjects
Non-ulcer dyspepsia    85 (33.4)    55 (64.7)   55 (32.7)
GORD     45 (17.7)    29 (64.4)   29 (17.2)
Duodenal ulcer    40 (15.7)    26 (65)   26 (15.4)
Gastric ulcer    24 (9.4)    17 (70.8)   17 (10.1)
Gastritis     8 (3.1)    6 (75)   6 (3.5)
Duodenitis    1 (0.3)    1 (100)   1 (0.5)
Gastroduodenitis    2 (0.7)    0 (00)   0 (00)
Gastric cancer    4 (1.5)    4 (100)   4 (2.3)
Gastric erosion    5 (1.9)    5 (100)   5 (2.9)
Antral gastritis    2 (0.7)    1 (50)   1 (0.5)
Atypical ORD    1 (0.3)    0 (00)   0 (00)
Others     37 (14.5)    24 (64.9)   24 (14.2)
Total     254    168
GORD=gastro-oesopharyngeal reflux disease; ORD=oesopharyngeal reflux disease.
Table II. Association between epidemiological risk factors and H. pylori infection (univariate analysis)
Variables and        No. of     H. pylori  H. pylori 
categories         cases (%)    +ve (%)     -ve (%)     OR (95% CI)       χ2 test  p-value
Age (yrs)
15 - 24          10 (4)     8 (80)  2 (20)     1.00 (0.06 - 17.08)        0.31     1.0
25 - 34          33 (13)    21 (63.6)  12 (36.4)     0.44 (0.04 - 2.78)        0.94     0.5
35 - 44          40 (16)    25 (62.5)  15 (37.5)     0.42 (0.04 - 2.65)        0.45     0.5
45 - 54          70 (28)    51 (73)  19 (27)     0.67 (0.06 - 3.82)        0.01     1.0
55 - 64          47 (18)    35 (74.5)  12 (25.5)     0.73 (0.07 - 4.45)        0.00     1.0
>65          54 (21)    28 (51.8)  26 (48.2)     0.27 (0.03 - 1.55)        1.69     0.2
Gender
Male          90 (35.4)    54 (60)  36 (40)                1 
Female          164 (65.6)    114 (69.5) 50 (30.5)     1.45 (0.82 - 2.57)        1.47     0.2
Antibiotic treatment 
Yes          16 (6.3)    14 (87.5)  2 (12.5)     3.82 (0.84 - 35.27)        2.53     0.11
No          238 (93.7)    154 (64.7) 84 (35.3)                1
Smoking
Yes          168 (66)    71 (42.3)  97 (57.7)     0.64 (0.36 - 1.11)        2.45     0.1
No          86 (34)    46 (53.5)  40 (46.5)                1
Alcohol consumption
Yes          168 (66)    60 (35.7)  108 (64.3)     1.15 (0.64 - 2.07)        0.13     0.7
No          86 (34)    28 (32.6)  58 (67.4)                1
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coloured patients. However, both our studies reported a higher 
prevalence among coloureds than whites. The high prevalence of H. 
pylori infection among coloured and black South Africans compared 
with whites could partly be explained by other known risk factors for 
H. pylori, particularly socio-economic determinants such as lower 
income, lower educational levels, and household crowding.9,10
Females – particularly blacks – had a higher prevalence (71.6%) 
than males (55.1%). Some studies have found a higher prevalence 
among women, but many have found no gender-based difference.24 It 
is possible that the risk of acquisition does not differ between the sexes. 
We speculate that females are more likely to have infections (such as 
genito-urinary infections) that are eradicated by antimicrobials such 
as metronidazole, which is used for other micro-organisms and 
commonly selects for H. pylori-resistant strains.2 Although we tried 
to ensure that our subjects had not been on antimicrobials for 3 
preceding months, their use cannot be ruled out.
We also observed that H. pylori infection prevalence increased 
with age, similarly to the results of Chong et al.25 The organism is 
ubiquitous, with acquisition in childhood being the rule. In our study, 
alcohol consumption and smoking were not significantly associated 
with H. pylori infection (p>0.05), although the OR (OR 1.15; 95% CI 
0.64 - 2.07) indicates that alcohol consumption may be a risk factor 
for H. pylori infection. H. pylori prevalence among alcohol consumers 
has been suggested to be lower than that in non-drinkers because 
alcohol may kill the organism in the stomach; however, this remains 
a matter for speculation.14
In conclusion, the prevalence of H. pylori is high in dyspeptic 
patients in Eastern Cape province. The ORs indicate that gender, 
antibiotic treatment and alcohol consumption may be risk factors 
for infection. These findings have clinical and epidemiological 
significance and therefore call for more comprehensive studies 
involving molecular epidemiology and genetic typing methods, to 
further elucidate the situation.
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LIVE LAPAROSCOPIC PAEDIATRIC WORKSHOP
12 - 14 November 2010 
The Division of Paediatric Surgery will be hosting a Live Laparoscopic Paediatric Workshop at Chris Hani Baragwanath Hospital on 
12 - 14 November 2010. The international expert will be Dr Joe Curry, the lead paediatric surgeon at Great Ormond Street Hospital, 
London.
In addition to the surgical programme, a free paper session will be held on Sunday 14 November, from which a dedicated issue of the 
SA Journal of Surgery will be published in 2011.
